On Tuesday March 5, AstraZeneca announced “an ambitious expansion and localization plan” that will see five of the international pharmaceutical company’s flagship drugs manufactured in Algeria over the next five years. Read more…
Towards pharmaceutical self-sufficiency
Algeria has taken a crucial step in its strategy of pharmaceutical self-sufficiency, with the official inauguration of the second private bioequivalence center launched by Clinica Group. Read more…